Hyperbaric Oxygen Therapy: Indications, Contraindications, and Treatment Protocols
Primary Recommendation
Hyperbaric oxygen therapy (HBOT) should be administered at 2.0-3.0 ATA for 60-120 minutes per session, with 100% oxygen delivery, for the 15 approved indications established by the Undersea and Hyperbaric Medicine Society, including carbon monoxide poisoning, chronic refractory wounds, delayed radiation injury, and acute arterial insufficiencies 1.
Approved Indications
HBOT has three main therapeutic categories 1:
Emergency Medicine Applications
- Carbon monoxide poisoning: Three hyperbaric oxygen treatments within 24 hours of presentation reduce cognitive sequelae by approximately 50% at 6 weeks, 6 months, and 12 months compared to normobaric oxygen 2
- Acute arterial insufficiencies 3
- Acute traumatic ischemia
Wound Healing Acceleration
- Diabetic foot ulcers: HBOT improves oxygenation, neovascularization, and decreases inflammation in chronic wounds 3
- Delayed radiation injury (soft tissue and bony necrosis) 3
- Chronic refractory osteomyelitis 3
- Compromised skin grafts and flaps
Antimicrobial Effects
- Necrotizing soft tissue infections
- Gas gangrene
- Intracranial abscess
Treatment Protocol
Standard Parameters 1
- Pressure: 1.5-3.0 ATA (typically 2.0-2.5 ATA)
- Duration: 60-120 minutes per session
- Oxygen concentration: 100% O₂
- Frequency: Varies by indication; for CO poisoning, three treatments within 24 hours 2
Special Considerations for Carbon Monoxide Poisoning
HBOT should be considered for all serious acute CO poisoning cases 2. Continue normobaric 100% oxygen until hyperbaric treatment begins.
Risk factors for cognitive impairment (though none are 100% predictive) 2:
- Age ≥36 years
- Exposure ≥24 hours
- Loss of consciousness
- COHb ≥25%
Important caveat: Patients with the APOE ε4 allele (14-25% of population) may not derive benefit from HBOT for CO poisoning, while those without this allele show significant reduction in cognitive sequelae 2. However, since most individuals lack the ε4 allele and genotyping delays treatment, HBOT is recommended for all eligible patients.
Contraindications
Absolute Contraindications 4
- Untreated pneumothorax (most critical absolute contraindication)
Relative Contraindications 4
- Upper respiratory infections (risk of barotrauma)
- Chronic obstructive pulmonary disease with CO₂ retention
- Uncontrolled high fever
- Seizure disorders (oxygen toxicity risk)
- Pregnancy (relative; risk-benefit must be carefully weighed)
- Claustrophobia (may require sedation or monoplace chamber)
Role in Methemoglobinemia
For symptomatic methemoglobinemia, hyperbaric oxygen therapy serves as a second-line treatment when methylene blue fails or is contraindicated 5. The treatment algorithm is:
- First-line: Methylene blue 1-2 mg/kg IV (up to 5.5 mg/kg total)
- Second-line (if no response after 30 minutes): Exchange transfusion or HBOT 5
Risks and Complications
Common Adverse Effects 4
- Barotrauma (middle ear, sinuses, lungs)
- Oxygen toxicity (CNS seizures, pulmonary toxicity with prolonged exposure)
- Myopia (temporary, reversible)
- Claustrophobia
Prevention Strategies
- Ensure patients can equalize middle ear pressure (teach Valsalva maneuver)
- Screen for respiratory infections before treatment
- Monitor for signs of oxygen toxicity during sessions
- Provide air breaks during longer treatments to reduce CNS oxygen toxicity risk
Patient Selection Criteria
Must Verify Before Treatment 4
- No untreated pneumothorax (obtain chest X-ray if any suspicion)
- Ability to equalize ear pressure (critical for preventing barotrauma)
- No active upper respiratory infection
- Hemodynamic stability for chamber transport
Special Populations
Pediatric patients: No marked differences in manifestations versus adults for CO poisoning, though communication limitations may complicate assessment 2
Pregnant patients: Decision must be multidisciplinary, weighing hypoxia risk to fetus against potential teratogenic effects 5
Common Pitfalls to Avoid
Delaying HBOT for CO poisoning while waiting for COHb levels: Treat based on clinical presentation; even patients with "mild" poisoning can develop delayed cognitive sequelae 2
Assuming normal pulse oximetry rules out need for HBOT: Pulse oximetry cannot distinguish carboxyhemoglobin from oxyhemoglobin 2
Missing pneumothorax screening: This is the most critical contraindication and must be ruled out before pressurization 4
Inadequate patient preparation: Failure to teach ear equalization techniques leads to treatment interruption and barotrauma 4